Position in JNJ
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$348,700
+$13,818 QoQ
Shares Held
1,373
+0.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.27%
of 13F equity value
Holder Rank
#4,030
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BELLEVUE ASSET MANAGEMENT, LLC holds $3,379,910 across 10 Drug Manufacturers - General names. JNJ ranks #3 (10.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMGN |
Amgen Inc
|
5,076 | $1,838,121 | |
| 2 | LLY |
ELI LILLY & Co
|
574 | $688,472 | |
| 3 | JNJ |
Johnson & Johnson
This page
|
1,373 | $348,700 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
4,400 | $253,528 | |
| 5 | MRK |
Merck & Co., Inc.
|
723 | $92,905 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
688 | $86,921 | |
| 7 | PFE |
Pfizer Inc
|
1,429 | $34,410 | |
| 8 | GSK |
GSK plc
|
482 | $25,266 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $348,700 | 1,373 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $334,882 | 1,370 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $324,290 | 1,567 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $289,811 | 1,563 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $238,290 | 1,560 | Shares | Sole | 2025-07-23 | |
| 2025-03-31 | $257,881 | 1,555 | Shares | Sole | 2025-04-28 | |
| 2024-12-31 | $224,305 | 1,551 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $246,007 | 1,518 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $221,578 | 1,516 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $259,589 | 1,641 | Shares | Sole | 2024-04-26 | |
| 2023-12-31 | $256,740 | 1,638 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $254,807 | 1,636 | Shares | Sole | 2023-10-25 | |
| 2023-06-30 | $270,294 | 1,633 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $254,355 | 1,641 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $289,352 | 1,638 | Shares | Sole | 2023-01-23 | |
| 2022-09-30 | $267,420 | 1,637 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $290,051 | 1,634 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $289,239 | 1,632 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $278,844 | 1,630 | Shares | Sole | 2022-02-03 | |
| 2021-09-30 | $273,096 | 1,691 | Shares | Sole | 2021-11-05 | |
| 2021-06-30 | $278,245 | 1,689 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $289,091 | 1,759 | Shares | Other | 2021-05-12 | |
| 2020-12-31 | $276,674 | 1,758 | Shares | Other | 2021-02-11 | |
| 2020-09-30 | $269,026 | 1,807 | Shares | Other | 2020-11-12 | |
| 2020-06-30 | $338,496 | 2,407 | Shares | Other | 2020-07-31 | |
| 2020-03-31 | $530,945 | 4,049 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||